Dana Farber Cancer Institute Clinical Trials ProjectManager — Boston, Massachusetts

Dana Farber Cancer Institute Clinical Trials ProjectManager is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Clinical Trials ProjectManager has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer, Advanced Solid Tumors, Cowden Syndrome.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Clinical Trials ProjectManager?

Dana Farber Cancer Institute Clinical Trials ProjectManager has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Clinical Trials ProjectManager conducted?

Dana Farber Cancer Institute Clinical Trials ProjectManager has 1 clinical trials on record. Their work covers Breast Cancer, Advanced Solid Tumors, Cowden Syndrome.

Is Dana Farber Cancer Institute Clinical Trials ProjectManager accredited by Crixeo Health?

Dana Farber Cancer Institute Clinical Trials ProjectManager has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Clinical Trials ProjectManager?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.